STOCK TITAN

Sharecare confirms receipt of unsolicited proposal from Claritas Capital

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Sharecare confirms receipt of unsolicited proposal from Claritas Capital
Positive
  • Claritas Capital has made a non-binding proposal to acquire all outstanding shares of Sharecare for between $1.35 and $1.80 per share
Negative
  • None.

ATLANTA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, confirmed that it has received an unsolicited preliminary non-binding proposal from Claritas Capital to acquire all of the outstanding shares of common stock of the Company, not already beneficially owned by Claritas and its affiliated funds, for cash consideration of between $1.35 and $1.80 per share. Consistent with its fiduciary duties, the Company's Board of Directors will carefully review Claritas’ proposal with the Board’s advisors and pursue the course of action it determines to be in the best interests of the Company and all of its stockholders.

Sharecare stockholders do not need to take any action at this time. There is no certainty that any transaction will be consummated, and Sharecare does not intend to comment further unless it determines that additional disclosure is appropriate. The proposal was required to be disclosed by Claritas under Regulation 13D by the U.S. Securities and Exchange Commission.

About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Media Relations: pr@sharecare.com

Investor Relations: investors@sharecare.com


FAQ

What is the proposal from Claritas Capital?

Claritas Capital has proposed to acquire all outstanding shares of Sharecare for a cash consideration of between $1.35 and $1.80 per share.

What will Sharecare's Board of Directors do?

Sharecare's Board of Directors will carefully review Claritas' proposal with the Board's advisors and determine the best course of action for the company and its stockholders.

Do Sharecare stockholders need to take any action?

No, Sharecare stockholders do not need to take any action at this time.

Is the transaction certain to be consummated?

There is no certainty that the transaction will be consummated.

Will Sharecare provide further comments on the proposal?

Sharecare does not intend to comment further unless it determines that additional disclosure is appropriate.

Sharecare, Inc.

NASDAQ:SHCR

SHCR Rankings

SHCR Latest News

SHCR Stock Data

250.24M
288.23M
9.85%
46.64%
1.91%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States of America
ATLANTA

About SHCR

sharecare is the digital health company that helps people manage all their health in one place. the sharecare platform provides each person – no matter where they are in their health journey – with a comprehensive and personalized health profile, where they can dynamically and easily connect to the information, evidence-based programs and health professionals they need to live their healthiest, happiest and most productive life. with award-winning and innovative frictionless technologies, scientifically validated clinical protocols and best-in-class coaching tools, sharecare helps providers, employers and health plans effectively scale outcomes-based health and wellness solutions across their entire populations.